Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma

Clinical trial NCT03061188 · COMPLETED

Trial details

NCT number: NCT03061188
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Neoplasm Aggressive Non-Hodgkin Lymphoma Recurrent Solid Neoplasm Refractory Mantle Cell Lymphoma T-Cell Non-Hodgkin Lymphoma Unresectable Solid Neoplasm

Start date: 2017-05-23
Primary completion: 2018-03-11
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.